Evgenia Gourgari1, Mihriye Mete2, Margarita Dimatulac3, Fran Cogen4, Tammy Brady5. 1. Division of Pediatric Endocrinology, Department of Pediatrics, Georgetown University, Washington, DC, United States of America. Electronic address: eg685@georgetown.edu. 2. MedStar Health Research Institute, Hyattsville, MD, United States of America. 3. Division of Pediatric Endocrinology, Department of Pediatrics, Children's National Health Systems, George Washington University, Washington, DC, United States of America. 4. Clinical Research Unit, Georgetown University, Washington, DC, United States of America. 5. Division of Pediatric Nephrology, Department of Pediatrics, John Hopkins University, Baltimore, MD, United States of America.
Abstract
AIMS: To determine whether sleep blood pressure (BP) is associated with increased cardiovascular disease (CVD) risk in youth with type 1 diabetes (T1DM). METHODS: We enrolled youth with T1DM, 12-21 years old. Carotid-femoral Pulse Wave Velocity (PWVcf) assessed arterial stiffness, a CVD marker. Sleep systolic and diastolic BP variables were obtained from 24-hour BP Monitoring. Linear regression models analyzed the relationship of each BP variable with PWVcf, adjusted for HbA1c. Correlation of sleep BP with urine microalbumin-to-creatinine ratio (UAC) was examined. RESULTS: Nocturnal hypertension was found in 36% and abnormal dipping in 48% of the 25 participants, aged 17.7 ± 2.2 years old. Sleep systolic BP [beta = 0.039, 95% Confidence Interval (CI; 0.006-0.073)], diastolic BP [beta = 0.058, 95% CI (0.003-0.114)], Mean Arterial Pressure (MAP) [beta = 0.075, 95% CI (0.018-0.131)] and MAP index [beta = 3.547, 95% CI (0.867-6.227)] were significantly associated with PWVcf. Sleep diastolic BP, load, MAP correlated with UAC. CONCLUSIONS: Blood pressure alterations during sleep are common in youth with T1DM and they are associated with arterial stiffness and UAC. Larger studies are needed to confirm our results and examine whether interventions that target sleep and night-time BP could decrease CVD risk.
AIMS: To determine whether sleep blood pressure (BP) is associated with increased cardiovascular disease (CVD) risk in youth with type 1 diabetes (T1DM). METHODS: We enrolled youth with T1DM, 12-21 years old. Carotid-femoral Pulse Wave Velocity (PWVcf) assessed arterial stiffness, a CVD marker. Sleep systolic and diastolic BP variables were obtained from 24-hour BP Monitoring. Linear regression models analyzed the relationship of each BP variable with PWVcf, adjusted for HbA1c. Correlation of sleep BP with urine microalbumin-to-creatinine ratio (UAC) was examined. RESULTS: Nocturnal hypertension was found in 36% and abnormal dipping in 48% of the 25 participants, aged 17.7 ± 2.2 years old. Sleep systolic BP [beta = 0.039, 95% Confidence Interval (CI; 0.006-0.073)], diastolic BP [beta = 0.058, 95% CI (0.003-0.114)], Mean Arterial Pressure (MAP) [beta = 0.075, 95% CI (0.018-0.131)] and MAP index [beta = 3.547, 95% CI (0.867-6.227)] were significantly associated with PWVcf. Sleep diastolic BP, load, MAP correlated with UAC. CONCLUSIONS: Blood pressure alterations during sleep are common in youth with T1DM and they are associated with arterial stiffness and UAC. Larger studies are needed to confirm our results and examine whether interventions that target sleep and night-time BP could decrease CVD risk.
Authors: M P Villa; G Multari; M Montesano; J Pagani; M Cervoni; F Midulla; E Cerone; R Ronchetti Journal: Diabetologia Date: 2000-06 Impact factor: 10.122
Authors: George S Stergiou; Christina V Alamara; Eleanna V Salgami; Iraklis N Vaindirlis; Catherine Dacou-Voutetakis; Theodore D Mountokalakis Journal: Blood Press Monit Date: 2005-06 Impact factor: 1.444
Authors: Robert H Fagard; Hilde Celis; Lutgarde Thijs; Jan A Staessen; Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer Journal: Hypertension Date: 2007-11-26 Impact factor: 10.190
Authors: Axel Dost; Christoph Klinkert; Thomas Kapellen; Andreas Lemmer; Andrea Naeke; Matthias Grabert; Joachim Kreuder; Reinhard W Holl Journal: Diabetes Care Date: 2008-01-03 Impact factor: 19.112
Authors: Joseph T Flynn; Stephen R Daniels; Laura L Hayman; David M Maahs; Brian W McCrindle; Mark Mitsnefes; Justin P Zachariah; Elaine M Urbina Journal: Hypertension Date: 2014-03-03 Impact factor: 10.190
Authors: Esben Laugesen; Klavs W Hansen; Søren T Knudsen; Mogens Erlandsen; Eva Ebbehøj; Per L Poulsen Journal: Blood Press Monit Date: 2010-02 Impact factor: 1.444
Authors: Sun Hee Lee; Jae Hyun Kim; Min Jae Kang; Young Ah Lee; Sei Won Yang; Choong Ho Shin Journal: Diabetes Care Date: 2011-09-12 Impact factor: 19.112
Authors: Evgenia Gourgari; Martin P Playford; Umberto Campia; Amit K Dey; Fran Cogen; Stephanie Gubb-Weiser; Mihriye Mete; Sameer Desale; Maureen Sampson; Allen Taylor; Kristina I Rother; Alan T Remaley; Nehal N Mehta Journal: Cardiovasc Diabetol Date: 2018-12-19 Impact factor: 9.951
Authors: Dana Dabelea; Jennifer W Talton; Ralph D'Agostino; R Paul Wadwa; Elaine M Urbina; Lawrence M Dolan; Stephen R Daniels; Santica M Marcovina; Richard F Hamman Journal: Diabetes Care Date: 2013-10-07 Impact factor: 19.112